What is Farxiga-dapagliflozin?
Dapagliflozin, marketed as Farxiga among other brand names, is an oral anti-diabetic medication. It belongs to the class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Dapagliflozin works by blocking the reabsorption of glucose in the kidneys, thereby increasing urinary excretion and lowering blood sugar levels. This mechanism helps in managing type 2 diabetes and reducing the risk of major adverse cardiovascular events. The medication is available in tablet form for oral administration.
What is Farxiga-dapagliflozin used for?
Dapagliflozin, marketed under the brand name Farxiga, is an oral antidiabetic medication that belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. It works by inhibiting the reabsorption of glucose in the kidneys, thereby promoting its excretion into the urine and lowering blood sugar levels.
Farxiga is primarily used for the treatment of type 2 diabetes mellitus and has also been approved for the treatment of heart failure with reduced ejection fraction in adults. In patients with type 2 diabetes, Farxiga helps to reduce glucose production in the liver, lower insulin resistance, and promote weight loss, all of which contribute to improved glycemic control. The medication’s effect on blood sugar levels is achieved through its mechanism of action as an SGLT2 inhibitor, where it prevents the kidneys from reabsorbing glucose back into the bloodstream.
In addition to its antidiabetic effects, Farxiga has been found to have benefits in patients with heart failure. By reducing blood pressure and promoting diuresis, the medication helps to alleviate symptoms associated with fluid overload and decrease the risk of hospitalization for cardiovascular events. The efficacy and safety profile of Farxiga make it a valuable addition to antidiabetic regimens and a treatment option for patients with heart failure.
Farxiga is available in tablet form and should be taken orally once daily, regardless of meals or snacks. Common side effects associated with the use of Farxiga include vaginal yeast infections, urinary tract infections, and gastrointestinal symptoms such as diarrhea or nausea. The medication’s safety profile and efficacy make it a valuable treatment option for patients with type 2 diabetes and heart failure.
Farxiga-dapagliflozin side effects
- Increased risk of genital yeast infections
- Urinary tract infections
- Hypoglycemia when used with insulin or other diabetes medications
- Nausea
- Vomitings
- Diarrhea
- Headache
- Dizziness
- Weakness
- Joint pain or swelling
- Blurred vision
- Abnormal liver function tests
- Increased risk of serious infections (such as pneumonia, bronchitis, and urinary tract infections)
- Pancreatitis
- Hyperkalemia (high potassium levels)
- Kidney problems or worsening kidney disease
- Bone fractures (increased risk)
- Allergic reactions (rash, itching, hives)
Disclaimer
The content on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The information provided here is based on general research and may not apply to individual circumstances. We do not guarantee the accuracy or completeness of any content on this website. Always consult with a healthcare professional before making any changes to your medication or health routine.